Can you get medical cannabis for IBS in the UK?

Irritable bowel syndrome appears on UK clinic condition lists, and it has one of the thinnest evidence bases of anything on those lists. The controlled studies that exist measured gut movement in a laboratory, not whether anyone felt better.

The short answer

  • IBS is assessed case by case, and no cannabis-based product is licensed for it in the UK.
  • The trial evidence measures gut transit, not symptom relief — a meaningful difference.
  • NICE recommends dietary and psychological approaches first, including low-FODMAP with a dietitian.
  • Red flag symptoms need investigating before IBS is accepted as the explanation.
  • Cyclical vomiting from heavy cannabis use can be mistaken for IBS and is made worse by more cannabis.

Is irritable bowel syndrome treated with medical cannabis in the UK?

IBS appears on the condition lists UK private clinics publish, and is assessed case by case. It is not an NHS treatment, nothing is licensed for it, and the evidence behind it is weaker than for almost anything else on this site.

UK management of IBS, set out in NICE guideline CG61, starts with diet and lifestyle: regular meals, adjusting fibre by IBS subtype, limiting caffeine and alcohol, and a low-FODMAP diet delivered by a trained dietitian where first-line advice has not worked. Antispasmodics, laxatives or loperamide are used by symptom pattern, low-dose tricyclic antidepressants are recommended where those fail, and psychological therapies including gut-directed hypnotherapy have real evidence behind them.

A specialist will want to know that route has genuinely been travelled — and that the diagnosis is right. IBS is a diagnosis made after coeliac disease, IBD and other causes have been considered, not a label for unexplained gut symptoms.

What the evidence actually shows

There is no randomised trial showing that cannabis-based medicines relieve IBS symptoms. The controlled studies that exist measured how quickly things move through the colon — a physiological measure, not a patient outcome.

A randomised pharmacodynamic and pharmacogenetic trial published in Neurogastroenterology and Motility gave dronabinol, a synthetic THC, or placebo to patients with IBS and measured colonic transit and motility. It found reduced fasting colonic motility, with effects greatest in diarrhoea-predominant IBS and influenced by genetic variation in cannabinoid receptor and endocannabinoid enzyme genes. That is a real pharmacological effect on the gut. It is not a demonstration that people's symptoms improved.

Systematic reviews of the area consistently conclude that evidence for cannabinoids in IBS is insufficient to support their use. Where UK patients with IBS are prescribed privately, the rationale is generally borrowed from the chronic pain literature rather than from IBS-specific evidence, and a specialist should say so.

The study behind that paragraph

Wong BS, Camilleri M, Eckert D, et al. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterology and Motility. 2012;24(4):358-e169. A randomised placebo-controlled trial measuring colonic transit and motility rather than symptom relief; effects were greatest in diarrhoea-predominant IBS.

Read the paper →

What a specialist will want to see

There is no UK list of qualifying conditions, so nothing here entitles you to a prescription. A specialist works through your history and decides whether a monitored trial is justified for you. For irritable bowel syndrome they will typically look at:

The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?

Risks and reasons a specialist may say no

There is a specific trap in IBS. Cannabinoid hyperemesis syndrome — cycles of severe nausea and vomiting, often relieved temporarily by hot showers — is caused by regular heavy cannabis use and is frequently mistaken for a functional gut disorder. Treating it with more cannabis makes it worse.

Cannabis also slows gut transit, which may help diarrhoea-predominant IBS and worsen constipation-predominant IBS. Symptom relief in a condition diagnosed by exclusion carries the risk of masking something that was missed, so red flag symptoms should always be investigated rather than medicated. The general cautions on drowsiness, driving, psychosis history and pregnancy apply as elsewhere.

If you want to take this further

The useful next step is a proper assessment, not a better list. Gather your diagnosis, the treatments you have already tried and what happened with each, and your current medicines — that is what a specialist needs in order to give you a straight answer.

The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If irritable bowel syndrome is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.

Frequently asked questions

Can I get medical cannabis for IBS in the UK?

IBS appears on UK clinic condition lists and is assessed case by case. Nothing is licensed for it, it is not available for this on the NHS, and the evidence base is among the weakest of any condition commonly listed.

Is there evidence that cannabis helps IBS symptoms?

No randomised trial has shown symptom relief. The controlled studies measured colonic transit and motility — how quickly things move through the gut — and found effects, particularly in diarrhoea-predominant IBS. Systematic reviews conclude the evidence is insufficient to support use.

Could cannabis be causing my symptoms?

It is worth checking. Cannabinoid hyperemesis syndrome causes cycles of severe nausea and vomiting in regular heavy cannabis users, is often temporarily relieved by hot showers, and is commonly mistaken for a functional gut disorder. Using more cannabis makes it worse. Tell the specialist about any current use.

What should I try first?

NICE recommends dietary and lifestyle measures, including a low-FODMAP diet delivered by a trained dietitian, then medicines matched to your symptom pattern, then low-dose tricyclics or psychological therapies such as gut-directed hypnotherapy. Those have far better evidence.

Sources and further reading

Every factual statement on this page is drawn from the following public sources. Links open in a new tab and are not affiliated with Flora House.

  1. Wong BS, et al. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterology and Motility (2012)
  2. NICE guideline CG61: Irritable bowel syndrome in adults
  3. NHS: Irritable bowel syndrome (IBS)
  4. NICE guideline NG144: Cannabis-based medicinal products
  5. NHS: Medical cannabis (and cannabis oils)
  6. House of Commons Library briefing CBP-8355: Medical use of cannabis
  7. MHRA: The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use

Patient guide · Written by the Flora House editorial team · Last reviewed: 31 August 2026